NETHERLANDS - BioGeneration and PPM Oost invest in NovioGendix

Founded in 2006, NovioGendix offers Molecular Diagnostics Services through its accreditated laboratory, and performs research in the field of the discovery of new and better diagnostic markers for cancer. The first molecular diagnostic PCA3 test is now available with full CE Mark.

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Early-stage
• Benelux